Your browser doesn't support javascript.
loading
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia.
Scheffold, Annika; Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Bloehdorn, Johannes; Ghia, Paolo; Yahiaoui, Anella; Dolnik, Anna; Blätte, Tamara Jacqueline; Bullinger, Lars; Dheenadayalan, Rashmi Priyadharshini; Li, Li; Schneider, Christof; Chen, Shih-Shih; Chiorazzi, Nicholas; Dietrich, Sascha; Seiffert, Martina; Tannheimer, Stacey; Döhner, Hartmut; Mertens, Daniel; Stilgenbauer, Stephan.
Afiliación
  • Scheffold A; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Jebaraj BMC; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Bloehdorn J; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Ghia P; Division of Experimental Oncology, Department of Onco-Hematology, Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Yahiaoui A; Gilead Sciences Inc., Foster City, CA.
  • Dolnik A; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany.
  • Blätte TJ; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany.
  • Bullinger L; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine, Berlin, Germany.
  • Dheenadayalan RP; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Li L; Gilead Sciences Inc., Foster City, CA.
  • Schneider C; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Chen SS; The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY; and.
  • Chiorazzi N; The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY; and.
  • Dietrich S; Department of Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
  • Seiffert M; German Cancer Research Center, Heidelberg, Germany.
  • Tannheimer S; Gilead Sciences Inc., Foster City, CA.
  • Döhner H; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Mertens D; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Stilgenbauer S; German Cancer Research Center, Heidelberg, Germany.
Blood ; 134(6): 534-547, 2019 08 08.
Article en En | MEDLINE | ID: mdl-31010847
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Receptor IGF Tipo 1 / Fosfatidilinositol 3-Quinasa Clase Ia / Inhibidores de las Quinasa Fosfoinosítidos-3 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Receptor IGF Tipo 1 / Fosfatidilinositol 3-Quinasa Clase Ia / Inhibidores de las Quinasa Fosfoinosítidos-3 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Alemania